L.-E. Lins
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
- Dermatology top 5%
- Dermatology and Skin Diseases
Papers in
-
- Dialysis and Renal Disease Management 5
-
- Neurological and metabolic disorders 2
- Co-authors
- S. KENNETH PEHRSSON (9 shared papers)ÖSten Hägermark (2 shared papers)Mona Ståhle‐Bäckdahl (2 shared papers)Naomi Clyne (8 shared papers)Tomas Jogestrand (3 shared papers)Keith Eliasson (1 shared paper)S. B. Svenson (1 shared paper)Gunilla Källenius (1 shared paper)
In The Last Decade
L.-E. Lins
19 papers receiving 371 citations
Peers
Comparison fields: 5 of 76
- Nephrology 86
- Dermatology 76
- Endocrinology 36
- Immunology and Allergy 21
- Hepatology 25
Countries citing papers authored by L.-E. Lins
This map shows the geographic impact of L.-E. Lins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.-E. Lins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.-E. Lins more than expected).
Fields of papers citing papers by L.-E. Lins
This network shows the impact of papers produced by L.-E. Lins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.-E. Lins. The network helps show where L.-E. Lins may publish in the future.
Co-authors
The 25 scholars most cited alongside L.-E. Lins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 56 | |
| 2 | 1988 | 49 | |
| 3 | 1989 | 46 | |
| 4 | 1981 | 44 | |
| 5 | 2021 | 44 | |
| 6 | 2008 | 40 | |
| 7 | 2008 | 35 | |
| 8 | 1984 | 23 | |
| 9 | 2008 | 20 | |
| 10 | 1976 | 17 | |
| 11 | Heparin elimination and hemostasis in hemodialysis. | 1984 | 15 |
| 12 | Serum cobalt in relation to cardiac performance in patients with chronic renal failure | 1985 | 5 |
| 13 | 1992 | 3 | |
| 14 | Distribution of cobalt in myocardium, skeletal muscle and serum in exposed and unexposed rats | 1988 | 2 |
| 15 | Clonidine in mild to moderate hypertension: effects on blood pressure and serum lipoproteins. | 1985 | 2 |
| 16 | Serum cobalt in relation to residual renal function in uremic patients before and after renal transplantation | 1990 | 1 |
| 17 | The effect of chronic cobalt exposure on cardiac function in rats | 1991 | 1 |
| 18 | Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis. | 1991 | 1 |
| 19 | 1988 | 1 | |
| 20 | 2008 | 1 |
About L.-E. Lins
L.-E. Lins is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Dermatology, Nutrition and Dietetics and Cell Biology, having authored 20 papers that have together received 406 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (5 papers), Contact Dermatitis and Allergies (3 papers), Muscle metabolism and nutrition (2 papers), Dermatology and Skin Diseases (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Urticaria and Related Conditions (2 papers), Neurological and metabolic disorders (2 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Nephrology (86 citations), Dermatology (76 citations), Endocrinology (36 citations), Immunology and Allergy (21 citations) and Hepatology (25 citations). L.-E. Lins has collaborated with scholars based in Sweden, Denmark and Italy. Frequent co-authors include S. KENNETH PEHRSSON, ÖSten Hägermark, Mona Ståhle‐Bäckdahl, Naomi Clyne, Tomas Jogestrand, Keith Eliasson, S. B. Svenson, Gunilla Källenius, Stefan H. Jacobson and Kenneth Pehrsson. Their work appears in journals such as The Nephron journals/Nephron journals, Scandinavian Journal of Clinical and Laboratory Investigation, Journal of Internal Medicine, The Journal of Infectious Diseases and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.